Labgenomics Co., Ltd. (084650) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Labgenomics Co., Ltd. (084650:KRX), powered by AI.

Current Price
₩1,077
P/E Ratio
-1.2
Market Cap
80.0B
Sector
Common Stock
What is the Labgenomics Co., Ltd. stock price forecast?

Labgenomics Co., Ltd. is currently trading at ₩1,077. View real-time AI analysis on Alpha Lenz.

What is Labgenomics Co., Ltd. insider trading activity?

View the latest insider trading data for Labgenomics Co., Ltd. on Alpha Lenz.

What is Labgenomics Co., Ltd.'s P/E ratio?

Labgenomics Co., Ltd.'s P/E ratio is -1.2.

Labgenomics Co., Ltd.

KRX · 084650
₩1,077-38(-3.41%)Market closedKRX regular session 09:00–15:30 KST
Ask about Labgenomics Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Labgenomics Co., Ltd. trades at a P/E of -1.2 (undervalued) with modest ROE of -35.2%.

Ask for details

Company Overview

Labgenomics Co., Ltd. is a prominent biotechnology company that focuses on offering innovative diagnostic solutions through advanced genetic testing technologies. The primary function of Labgenomics is to develop and commercialize DNA-based testing systems which are critical for early disease detection and personalized medicine. The company is deeply involved in the healthcare and life sciences sectors, providing vital tools for genetic screening, cancer diagnostics, and prenatal testing. A notable feature of Labgenomics is its commitment to improving accuracy and accessibility in genetic diagnostics, which positions it as a key player in fostering precision medicine. As a part of the broader biopharmaceutical and healthcare ecosystem, Labgenomics plays a crucial role in enhancing patient outcomes via cutting-edge research and development. Its impact is significant for medical institutions, clinicians, and researchers who rely on robust genetic data to make informed decisions. Founded in South Korea, Labgenomics continues to advance the field of genomic diagnostics, contributing to the global push towards data-driven health solutions.

CEO류재학 대표이사
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2025

Profile

₩79,956,469,230Market Cap
₩88,161,338,250Revenue
74.24MShares Out
0Employees

Margins

34.76%Gross
-45.93%EBITDA
-60.70%Operating
-68.35%Pre-Tax
-73.02%Net

Valuation

-1.24P/E
0.53P/B
0.91EV/Sales
-3.18EV/EBITDA
-2.48P/FCF

Growth (CAGR)

-15.24%Rev 3Yr
-5.90%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-24.49%ROA
-35.18%ROE
-20.74%ROIC

Financial Health

₩6,761,972,740Cash & Cash Equivalents
₩73,765,324,190Net Debt
53.82%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Labgenomics Co., Ltd. (ticker: 084650) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $80.0B.

The current price is ₩1,077 with a P/E ratio of -1.24x and P/B of 0.53x.

ROE is -35.18% and operating margin is -60.70%. Annual revenue is $88.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Labgenomics Co., Ltd. (084650) Stock Forecast 2026 ₩1,077 — Price, Financials & Analyst Targets | Alpha Lenz